More than 670 million people have been infected with the SARS-CoV-2 virus that causes COVID-19 disease, and nearly 9 million have died. As of the date the global COVID-19 pandemic was declared, 11 March 2020, there is no effective drug to stop the virus from further infecting and mutating. The internal Babu™ Project, created and led by its founder, Steve Liebich, although not part of the substantive scope of Three Pillars, was created out of necessity to save lives. BAT-19 is a potential therapeutic and prophylactic drug for COVID-19 and, if successful, the first representative of a group of drugs for other droplet-transmitted viral diseases created from a single functional platform by Steve Liebich and Babu™.